Genentech enters agreement to develop autoimmune therapies

US-based biopharmaceutical company Parvus Therapeutics has entered into a collaboration and licensing agreement with Genentech, a subsidiary of Roche.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Genentech in $1.7bn immuno-oncology deal

27 February 2020 California-headquartered biotech Genentech has agreed to pay $30 million upfront to develop immuno-oncology therapies with UK-based Bicycle Therapeutics.

Big Pharma

Genentech and Samsung Bioepis settle patent dispute over cancer biosimilar

5 July 2019 US-based biotechnology company Genentech, a subsidiary of Roche, has entered into a settlement agreement with Samsung Bioepis, ending all patent litigation between the two companies.

Big Pharma

Tokyo court dismisses Genentech patent suit against Sandoz

4 June 2019 A Japanese court has dismissed a patent infringement lawsuit brought by Roche subsidiary Genentech against Sandoz, a division of Novartis.

More on this story

Americas

Genentech in $1.7bn immuno-oncology deal

27 February 2020 California-headquartered biotech Genentech has agreed to pay $30 million upfront to develop immuno-oncology therapies with UK-based Bicycle Therapeutics.

Big Pharma

Genentech and Samsung Bioepis settle patent dispute over cancer biosimilar

5 July 2019 US-based biotechnology company Genentech, a subsidiary of Roche, has entered into a settlement agreement with Samsung Bioepis, ending all patent litigation between the two companies.

Big Pharma

Tokyo court dismisses Genentech patent suit against Sandoz

4 June 2019 A Japanese court has dismissed a patent infringement lawsuit brought by Roche subsidiary Genentech against Sandoz, a division of Novartis.

More on this story

Americas

Genentech in $1.7bn immuno-oncology deal

27 February 2020 California-headquartered biotech Genentech has agreed to pay $30 million upfront to develop immuno-oncology therapies with UK-based Bicycle Therapeutics.

Big Pharma

Genentech and Samsung Bioepis settle patent dispute over cancer biosimilar

5 July 2019 US-based biotechnology company Genentech, a subsidiary of Roche, has entered into a settlement agreement with Samsung Bioepis, ending all patent litigation between the two companies.

Big Pharma

Tokyo court dismisses Genentech patent suit against Sandoz

4 June 2019 A Japanese court has dismissed a patent infringement lawsuit brought by Roche subsidiary Genentech against Sandoz, a division of Novartis.

More features

Life sciences leaders recognised at LSPN Awards USA 2025

UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body

LSPN: Counsel grapple with AI’s impact on training and critical thinking

'Nothing can stand in the way of our work': Ukraine resumes IP system

LSPN: Trump's policy storm causing chaos and confusion

Taylor Wessing expands in Europe with Paris team

LSPN: Using ‘the patentee’s friend’ in Section 112 claims

ResMed voids sleep apnoea tech patent at PTAB

Genentech enters agreement to develop autoimmune therapies

More on this story

Editor's picks

Editor's picks

More on this story

More on this story

More features